Peter Radovich
President chez MIRUM PHARMACEUTICALS, INC.
Fortune : 832 963 $ au 29/02/2024
Profil
Peter Radovich is President & Chief Operating Officer at Mirum Pharmaceuticals, Inc.
He previously occupied the position of Senior Vice President-Operations of Global Blood Therapeutics, Inc., Principal at Chiron Corp.
and Senior Director & VP-Program Leadership at Onyx Pharmaceuticals, Inc.
Peter Radovich received an MBA from the University of Washington and an undergraduate degree from Texas Christian University.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
25/03/2024 | 29 013 ( 0,06% ) | 832 963 $ | 29/02/2024 |
Postes actifs de Peter Radovich
Sociétés | Poste | Début |
---|---|---|
MIRUM PHARMACEUTICALS, INC. | President | 16/01/2024 |
Anciens postes connus de Peter Radovich
Sociétés | Poste | Fin |
---|---|---|
RAIN ONCOLOGY INC. | Director/Board Member | 25/01/2024 |
GLOBAL BLOOD THERAPEUTICS, INC. | Chief Operating Officer | 01/04/2020 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Director/Board Member | 01/09/2006 |
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Corporate Officer/Principal | 01/01/2006 |
Formation de Peter Radovich
University of Washington | Masters Business Admin |
Texas Christian University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
MIRUM PHARMACEUTICALS, INC. | Health Technology |
Entreprise privées | 4 |
---|---|
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Health Technology |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Health Technology |
Rain Oncology, Inc.
Rain Oncology, Inc. BiotechnologyHealth Technology Rain Oncology, Inc. is a clinical-stage precision oncology company, which focuses on developing and implement the precision oncology therapies for patients suffering from cancer. The company was founded by Avanish Vellanki and Robert Doebele in April 2017 and is headquartered in Newark, CA. | Health Technology |
Global Blood Therapeutics, Inc.
Global Blood Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. It also provides oral medicines for sickle cell diseases. The company was founded by Matthew P. Jacobson, Andrej Sali, Jack Taunton, Charles J. Homcy, Craig D. Muir, and David R. Phillips in February 2011 and is headquartered in South San Francisco, CA. | Health Technology |